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on the characterization of goat mesenchymal
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Nuradilla Mohamad-Fauzi1,3, Pablo J Ross1, Elizabeth A Maga1 and James D Murray1,2*Abstract
Background: There is considerable interest in using goats as models for genetically engineering dairy animals and
also for using stem cells as therapeutics for bone and cartilage repair. Mesenchymal stem cells (MSCs) have been
isolated and characterized from various species, but are poorly characterized in goats.
Results: Goat MSCs isolated from bone marrow (BM-MSCs) and adipose tissue (ASCs) have the ability to undergo
osteogenic, adipogenic and chondrogenic differentiation. Cytochemical staining and gene expression analysis show
that ASCs have a greater capacity for adipogenic differentiation compared to BM-MSCs and fibroblasts. Different
methods of inducing adipogenesis also affect the extent and profile of adipogenic differentiation in MSCs. Goat
fibroblasts were not capable of osteogenesis, hence distinguishing them from the MSCs. Goat MSCs and fibroblasts
express CD90, CD105, CD73 but not CD45, and exhibit cytoplasmic localization of OCT4 protein. Goat MSCs can be
stably transfected by Nucleofection, but, as evidenced by colony-forming efficiency (CFE), yield significantly different
levels of progenitor cells that are robust enough to proliferate into colonies of integrants following G418 selection.
BM-MSCs expanded over increasing passages in vitro maintained karyotypic stability up to 20 passages in culture,
exhibited an increase in adipogenic differentiation and CFE, but showed altered morphology and amenability to
genetic modification by selection.
Conclusions: Our findings provide characterization information on goat MSCs, and show that there can be significant
differences between MSCs isolated from different tissues and from within the same tissue. Fibroblasts do not exhibit
trilineage differentiation potential at the same capacity as MSCs, making it a more reliable method for distinguishing
MSCs from fibroblasts, compared to cell surface marker expression.
Keywords: Adipose, Bone marrow, Characterization, Differentiation, Goat, Mesenchymal stem cellsBackground
Mesenchymal stem cells (MSCs), also known as multi-
potent stromal cells, are one of the most studied adult
stem cells for their ease of culture ex vivo and their mul-
tipotentiality, as well as supportive functions in vivo. Be-
lieved to reside in virtually all post-natal tissues [1],
MSCs have been isolated and characterized from a var-
iety of tissue types, most commonly from bone marrow
[2,3] and adipose tissue [4]. Even though MSCs isolated* Correspondence: jdmurray@ucdavis.edu
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article, unless otherwise stated.from different tissues appear similar in morphology and
their ability to differentiate into osteogenic, chondrogenic
and adipogenic lineages [5], they can display phenotypical
differences, including in differentiation potential [6-9]
and cell surface proteins [10,11]. Bone marrow-derived
MSCs (BM-MSCs) have a higher capacity to differenti-
ate into osteogenic and chondrogenic lineages [6,7],
whereas adipose-derived MSCs (ASCs) are better at
differentiating into adipocytes [8,9]. The influence of
source tissue, along with variations due to species, donor,
and culture methods, have challenged the consistency of
reports in the literature and complicated the understand-
ing of MSC biology.
Goats are widely used as large animal models for bone
tissue engineering as they have knee joints that areCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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drogenic potential of MSCs, goat MSCs are utilized in
tissue engineering applications for bone and cartilage re-
generation, such as repairing segmental bone defects
[13,14] and restoring articular cartilage [15,16]. Some
studies also employed genetic engineering of goat MSCs
for the purpose of cell-based therapy, such as generating
GFP-positive MSCs for tracking engraftment of trans-
planted cells [17], enhancing differentiation potential of
transplanted MSCs via expression of transgenes [18] and
expressing factors to facilitate the tissue generation
process [19]. Reports on the characterization of goat
MSCs are relatively more recent and amount to little com-
pared to MSCs isolated from other more commonly used
species such as the human, mouse and pig. Many of the
reports utilizing goat MSCs, mostly from bone marrow,
for tissue engineering lack characterization information.
There are relatively few reports on goat MSCs isolated
from other tissues, such as adipose tissue [20,21] and um-
bilical cord [22,23]. Little information exists on compari-
sons between goat MSCs isolated from different source
tissues, and on comparisons with fibroblasts, which are
morphologically similar to and share characteristics with
MSCs [24,25].
Adipogenic differentiation in vitro is easy to characterize,
as distinct morphological changes that occur are easily
visualized and molecular markers of adipogenesis are
well-described. Exploring adipogenic differentiation of
MSCs in culture may provide a window into under-
standing adipogenesis, especially upstream in the path-
way where lineage commitment occurs. This cannot be
studied in pre-adipocyte cell lines such as 3T3-1 cells,
which are already lineage-committed. Additionally, study-
ing adipogenic differentiation in MSCs may have implica-
tions for meat animals such as goats and cows [26,27],
as intramuscular adipocyte differentiation is initiated by
MSCs [28]. As goat MSCs are researched extensively for
applications in bone and cartilage tissue regeneration,
measuring adipogenesis may provide valuable infor-
mation to inform the selection of MSC cultures for these
applications.
For use in experiments and clinical applications, MSCs
are needed in amounts that are larger than the starting
population isolated from a sample and must be ex-
panded in vitro. With increasing population doublings,
studies have observed an increase in doubling time [29],
increase in cellular senescence [30], changes in cell sur-
face marker profile [31], and loss in multipotentiality
[32,33]. This suggests that ex vivo culture conditions for
MSCs outside of their niches in vivo is not sufficient for
maintaining MSC characteristics over long-term expan-
sion. To date, changes in MSC characteristics due to
long-term ex vivo culture have not yet been character-
ized in MSCs isolated from goats.In this study, we report characterization of three lines
of putative MSCs isolated from bone marrow and adi-
pose tissue of neonatal kid goats. We provide a compari-
son between MSC lines isolated from the same tissue
type as well as from different source tissues. Osteogenic,
chondrogenic and adipogenic differentiation, as well as
the expression of cell surface markers, were investigated.
Adipogenic differentiation capacity was measured by
both the extent of Oil Red O staining and mRNA ex-
pression of genes involved in adipogenesis. These char-
acteristics also were compared to fibroblasts isolated
from goat ear tissue. Using MSCs, we also assessed colony-
forming efficiency, expression of pluripotency markers and
transfection efficiency as well as integration of an intro-
duced plasmid construct. BM-MSCs were also expanded
up to 20 passages, and examined for their adipogenic dif-
ferentiation, colony-forming efficiency, cell surface marker
expression and potential for genetic modification.
Methods
Isolation and establishment of cell lines
Bone marrow and adipose tissue samples were collected
from two male neonatal kid goats (9003 and 9004).
MSCs were isolated using methods described in Monaco
et al. [8]. Three lines were established: one bone marrow-
derived line from individual 9004 (9004 BM-MSC), as
well as one bone marrow- and one adipose-derived line
from individual 9003 (9003 BM-MSC and 9003 ASC,
respectively).
Ear fibroblasts (1014 EF) were isolated from a juvenile
(2–3 months old) male goat from the UC Davis herd. A
biopsy of the ear was taken and stored in PBS until it
was processed. The outer skin was removed with a scalpel,
and the remaining tissue was diced into approximately
3 mm× 3 mm pieces, which were plated in a 35-mm dish.
Fibroblasts that migrated out of the tissue were subse-
quently trypsinized and expanded. 1014 EF was used as a
control cell line for subsequent differentiation experiments
and cell surface marker analysis.
Unless otherwise noted, cells were cultured in expansion
medium: high glucose DMEM (Gibco Life Technologies
12100–046) with 10% fetal bovine serum (FBS, JR
Scientific), in 5% CO2 at 37°C. Cells were expanded by
passaging at 1:3 ratio at each passage, and were cryopre-
served in 75% DMEM, 10% DMSO and 15% FBS, to be
thawed at corresponding passages for subsequent experi-
ments. Passage 5 (P5) cells were used for all experiments
comparing different MSC lines with fibroblasts. 9004 BM-
MSC at passage 10 (P10), passage 15 (P15) and passage 20
(P20) cells were used for all experiments comparing MSCs
of different passages. MSCs and fibroblasts were counted
with a hemocytometer and seeded the same way within
each experiment. The term ‘MSCs’ in this report will be
used to refer to both BM-MSCs and ASCs.
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MSCs were counted and 150 cells were seeded in a
10-cm dish. The cells were then cultured in 10 mL expan-
sion medium for 10 d, without physical disturbance or
medium changes. At Day 10, cells were rinsed with
phosphate-buffered saline (PBS), fixed with 4% parafor-
maldehyde for 30 min, and stained with 0.5% crystal violet
solution for 10 min to visualize colonies. The number of
colonies per dish was determined under light microscopy,
with colonies of 50 cells or more counted as positive.
Colony-forming efficiency (CFE) was then expressed as
the percentage of colonies over the number of cells plated
at Day 0. This assay was done for each cell line in tripli-
cates (P5 MSCs) or 4 replicates (P10-20 MSCs), and the
experiment was repeated once more. Data from all repli-
cates were combined to get the average percent GFP-
positive cells for each cell line.
Karyotype analysis
To harvest mitotic chromosomes for karyotype analysis,
MSCs were cultured to 60-70% confluency and colcemid
was added to the culture medium at 0.07 μg/mL. After
incubation for 60 min at 37°C, culture medium was dis-
carded and the cells were trypsinized and centrifuged.
The cell pellet was resuspended in 0.075 mol/L KCl hypo-
tonic salt solution and incubated at 37°C for 20 min. Then,
Carnoy’s fixative (3 absolute methanol:1 glacial acetic acid)
was added to the suspension, after which cells were centri-
fuged and the supernatant discarded. The cell pellet was
resuspended in Carnoy’s fixative and incubated at room
temperature for 15 min, centrifuged again and the fixative
wash procedure repeated twice. Finally, the cell pellet was
resuspended in fixative and the cell suspension dropped
from a Pasteur pipette onto cold, wet slides. Slides were
air dried overnight, stained with 3% Giemsa solution and
air dried. Metaphase spreads were visualized under light
microscopy at 100X magnification, and images were taken
using an attached camera. Chromosomes were then
counted using ImageJ (National Institutes of Health)
to determine total chromosome number and presence or
absence of chromosomal abnormalities. Non-overlapping
chromosome spreads were picked for counting that were
roughly circular, with chromosomes spread sufficiently to
enable counting. For each cell line, at least 20 spreads were
counted.
Osteogenic differentiation assay
MSCs and fibroblasts were seeded at a density of 10,000
cells/cm2 in 6-well plates and cultured in expansion
medium to approximately 80% confluency in 2 d, then
the medium was replaced by osteogenic differentiation
medium: DMEM, 10% FBS, 100 nmol/L dexamethasone
(Sigma), 0.05 mmol/L ascorbic acid-2-phosphate (Sigma)
and 10 mmol/L β-glycerophosphate (Sigma). Cells werecultured in differentiation medium for 21 d, with medium
changes every 3 d. Control cells were cultured in expan-
sion medium in the same 6-well plate. After 21 d, cells
were rinsed with PBS twice, fixed with 4% paraformalde-
hyde for 30 min, rinsed three times with distilled water,
covered with 2% Alizarin Red S solution and incubated
at room temperature for 10 min. Cells were then rinsed
with distilled water and visualized under light and phase
microscopy.
Chondrogenic differentiation assay
Chondrogenic differentiation was carried out using the
micromass method described by Zuk et al. [4]. MSCs
and fibroblasts were trypsinized and resuspended in ex-
pansion medium to a concentration of 1 × 107 cells/mL.
Then, 10 μL drops of approximately 1 × 105 cells of the
cell suspension was carefully pipetted into the wells of
6-well plates. The cells were incubated for 2 h to allow
for attachment, and then the wells were carefully filled
with differentiation medium (or expansion medium for
control cells) without disturbing the cell clumps. Chon-
drogenic differentiation medium consisted of DMEM,
10% FBS, 0.1 μmol/L dexamethasone, 50 μg/mL ascorbic
acid-2-phosphate, 1X Insulin-Transferrin-Selenium (Life
Technologies), and 10 ng/mL TGF-β3 (Life Technologies),
which was added fresh each time. Cells were cultured for
21 d, with medium changes every 3 d. Cells were rinsed
with PBS and fixed with 4% paraformaldehyde at room
temperature for 15 min, after which they were incubated
in 0.1 N HCl (pH 1) for 5 min, then stained with 1% Alcian
Blue in 0.1 N HCl overnight. Cells were rinsed twice with
0.1 N HCl for 5 min with shaking to remove non-specific
staining, after which they were air-dried and visualized
under light microscopy.
Adipogenic differentiation assay
Two methods of inducing adipogenic differentiation were
investigated. In the first method (designated “Adipo I”),
MSCs and fibroblasts were plated in 6-well plates at a
density of 10,000 cells/cm2 and cultured to 80% con-
fluency. Then, expansion medium was replaced with adi-
pogenic induction medium: DMEM, 10% FBS, 1.0 μmol/L
dexamethasone, 0.5 mmol/L 3-isobutyl-1-methylxanthine
(Sigma), 200 μmol/L indomethacin (Sigma) and 10 μmol/L
insulin (Akron Biotech). Cells were cultured for 21 d with
medium changes every 3 d.
In the second method (designated “Adipo II”), adipo-
genesis was induced using the method described by
Pittenger et al. [34], with modifications. MSCs and fibro-
blasts were plated in 6-well plates at a density of 10,000
cells/cm2 and cultured to full confluency. Then, expansion
medium was replaced with adipogenic induction medium
(as described above) for 3 d, after which the medium was
replaced with adipogenic maintenance medium – DMEM,
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return to adipogenic induction medium. After three cycles
of induction, cells where maintained in adipogenic main-
tenance medium for another 7 d.
In both methods, control cells were cultured in expan-
sion medium instead of induction medium for the length
of the experiments. At the end of the assays, cells were
rinsed with PBS twice and fixed with 4% paraformalde-
hyde for 60 min. Cells were then rinsed with distilled
water and incubated in 60% isopropanol for 2–5 min. Fi-
nally, cells were covered with Oil Red O solution for
5 min, rinsed, and covered with hematoxylin as a counter-
stain for 1 min. Stained cells were visualized under light
microscopy. To quantify adipogenic differentiation cap-
acity, images of cells were captured to represent at least
4,000 cells per replicate of each cell line. Lipid-positive cells
that stained with Oil Red O were counted using ImageJ
(National Institutes of Health). When lipid-positive cells
were too sparse, each well of the plate was divided into sec-
tors, and positive cells were counted by hand using the
microscope. Adipocyte count is expressed as the percent-
age of lipid-positive cells over the total number of nuclei
counted. This assay was done in triplicates and the experi-
ment repeated once more.
RNA extraction and cDNA synthesis
Prior to RNA extraction, cells were harvested, centri-
fuged and flash frozen as pellets. For measuring the ex-
pression of cell surface markers, cells were harvested at
70-80% confluency. For measuring expression of adipo-
genic genes, cells were harvested at the end of the differ-
entiation assay. Total RNA was extracted using TRIzol
Reagent (Life Technologies) according to the manufac-
turer’s instructions. RNA quality was confirmed via agarose
gel electrophoresis, and 1 μg of total RNA was subse-
quently DNAse-treated (Thermo Scientific) and used for
first-strand cDNA synthesis using Oligo(dT) primers and
RevertAid First Strand cDNA Synthesis Kit (Thermo
Scientific) according to the manufacturer’s instructions.
RT-PCR
Published primer sequences were used for amplifying
GAPDH, OCT4, SOX2 [35] and NANOG [36]. Primer se-
quences for amplifying THY1 (CD90), NT5E (CD73),
ENG (CD105), PTPRC (CD45) and CD34 (CD34) were
designed based on caprine or bovine sequences using
Primer3 and spanned exon junctions or included in-
trons, to control for possible genomic DNA contam-
ination [Table 1]. Cycling parameters for amplifying
GAPDH, OCT4, SOX2 and NANOG were acquired from
the papers referenced, whereas cycling parameters used for
amplifying the other genes were as follows: initial denatur-
ation at 94°C for 2 min, followed by 32 cycles of denatur-
ation at 94°C for 30 s, annealing at respective temperaturesfor 30 s, 72°C for 40 s, and then a final extension at 72°C
for 5 min.
Quantitative RT-PCR
Primers for amplifying GAPDH [37], CD90, CD105,
CD73, PPARG [38] and FABP4 [39] are listed in Table 2.
Primer sets that were not obtained from references were
designed based on caprine or bovine sequences using
Primer3 and spanned exon junctions or included in-
trons. mRNA expression of these genes was quantified
using Fast SYBR Green Master Mix (Life Technologies)
on the ABI 7500 Fast thermocycler (Applied Biosystems),
using the following thermocycling parameters: 95°C for
20 s, followed by 40 cycles of 95°C for 3 s and 60°C for
30 s, followed by a melt curve stage of 95°C for 15 s, 60°C
for 1 minute, 95°C for 15 s and 60°C for 15 s. Relative gene
expression was obtained by normalizing with GAPDH ex-
pression as the internal control and using the 2-ΔΔCT
method [40,41], calculating differences in mRNA expres-
sion as fold changes relative to expression in 1014 EF for
comparisons between cell lines, or to 9004 BM-MSC at P5
for comparisons between passages.
Immunofluorescence
Cells of each cell line were plated into a 4-well plate. At
50-70% confluency after 2 d, the cells were rinsed with
PBS twice and fixed with 4% paraformaldehyde for
10 min at room temperature. After rinsing with PBS
three times, the cells were blocked with PBS-Tween
(PBST) and 3% normal donkey serum (NDS) for 30 min
at room temperature. Cells were probed with a goat
polyclonal primary antibody against human OCT4 (Santa
Cruz Biotechnology) (1:300) in PBST and 1% NDS over-
night at 4°C with shaking. After that, the cells were rinsed
with PBST and 1% NDS three times for 10 min each, and
then probed with a donkey anti-goat secondary antibody
(1:500), conjugated with Alexafluor 488, in PBST and 1%
NDS for 1 h at room temperature with shaking. Then, the
cells were rinsed in PBST three times for 10 min each. In
the last rinse, Hoescht stain was added at 10 μg/mL to
stain the nuclei. The wells were kept wet in PBS and the
cells were visualized under fluorescent microscopy. Bovine
blastocysts were used as a positive control. Blastocysts
were rinsed, blocked and probed as described above,
then stored in PBST until visualization. For visualization,
stained blastocysts were mounted on a glass slide in
Prolong Gold Anti-Fade reagent (Life Technologies).
Transfection efficiency of circular GFP (transient)
For transfection experiments, plasmid pEGFP-N1
(Clontech) was used. This 4.7 kb plasmid contains the en-
hanced green fluorescent protein gene (EGFP) controlled
by a human cytomegalovirus (CMV) promoter and the
neomycin resistance gene (NeoR) controlled by a simian
Table 1 Primer sequences used in RT-PCR
Gene Primer sequences (5’→ 3’) Product size, bp Anneal T, °C Source
GAPDH F: TCATGACCACAGTCCATGCCATCACT 253 60 [35]
R: GATGTCATCATATTTGGCAGGTTTCTCC
OCT4 F: AGGTGTTCAGCCAAACGACTATCTG 192 55 [35]
R: TCGGTTCTCGATACTTGTCCGCTT
NANOG F: GCCGAGGAATAGCAATGG 444 53 F: AY786437.2
R: TACAAATCTTCAGGCTGTATGTTG R: [36]
SOX2 F: TGCAGTACAACTCCATGACCAGCT 281 55 [35]
R: GTAGTGCTGGGACATGTGAAGTCTG
CD90 (THY1) F: GCACCATGAACCCTACCATC 241 55 NM_001034765.1
R: TTGGTTCGGGAGCTGTATTC
CD73 (NT5E) F: CTGAGACACCCGGATGAGAT 160 57 NM_174129.3
R: ACTGGACCAGGTCAAAGGTG
CD105 (ENG) F: AGATGCCAACATCACACAGC 129 60 NM_001076397.1
R: TCCAGACGAAGGAAGATGCT
CD45 (PTPRC) F: GGGAGGAGGGAAAGCAAACC 146 60 XM_005691061.1
R: GCAGCTCTTCCCCATTCCAG
CD34 (CD34) F: AGGTGTGCTCCTTGCTCCT 134 55 NM_174009
R: GCCCATCTCTCTCAGGTCAG
The sequences of primers used are listed with the genes amplified, PCR product sizes (bp), annealing temperatures and sources. Primers were acquired from the
indicated references, or designed using Primer3 based on the GenBank accessions provided.
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using PerfectPrep EndoFree Plasmid Maxi Kit (5 Prime)
according to manufacturer’s instructions, and then concen-
trated using a vacuum centrifuge until DNA concentration
was at least 1 μg/μL for use in transfection.
MSCs were counted with a hemocytometer, and 500,000
cells were aliquoted for transfection with 10 μg plasmidTable 2 Primer sequences used in quantitative RT-PCR
Gene Primer sequences (5’→ 3’) Pro
GAPDH F: TTGTGATGGGCGTGAACC
R: CCCTCCACGATGCCAAA
PPARG F: AAAGCGTCAGGGTTCCACTA
R: CCCGAACCTGATGGCGTTAT
FABP4 F: TGAGATGTCCTTCAAATTGGG
R: CTTGTACCAGAGCACCTTCATC
CD90 (THY1) F: GAATCCCACCGTCTCCAATA
R: CTTGTGGCTTCCTGTGTCCT
CD73 (NT5E) F: CTGAGACACCCGGATGAGAT
R: ACTGGACCAGGTCAAAGGTG
CD105 (ENG) F: GCAAAGCATCTTCCTTCGTC
R: GATTGCAGGAGAACGGTGAG
The sequences of primers used are listed with the genes amplified, PCR product siz
indicated references, or designed using Primer3 based on the GenBank accessionsDNA. Transfection was performed via the Nucleofector II
system (Lonza, Amaxa, Germany), using the Human MSC
Nucleofector kit. The bone marrow-derived cell lines (9004
BM-MSC and 9003 BM-MSC) were Nucleofected using
program G-017, whereas the adipose-derived cell line
(9003 ASC) were Nucleofected using program C-020. After
transfection, cells were plated in a T-25 flask for culture induct size, bp Anneal T, °C Source
127 60 [37]
201 60 [38]
101 60 [39]
190 60 XM_005689553.1
160 57 NM_174129.3
56 60 NM_001076397.1
es (bp), annealing temperatures and sources. Primers were acquired from the
provided.
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post-transfection using a fluorescent microscope. Transfec-
tion efficiency was expressed as the percentage of green
cells over total cells counted. This assay was done for each
cell line in triplicates (P5 MSCs) or 4 replicates (P10-20
MSCs), and the experiment was repeated once more. Data
from all replicates were combined to get the average
percent GFP-positive cells for each cell line.
Integration of NeoR construct
For these transfection experiments, pEGFP-N1 was
isolated using PerfectPrep EndoFree Plasmid Maxi Kit
(5 Prime) according to manufacturer’s instructions, and
then linearized by ApaLI digestion and purified by ethanol
precipitation. Plasmid DNA was resuspended in UltraPure
H2O (Gibco Life Technologies) such that DNA concentra-
tion was at least 1 μg/μL for use in transfection. MSCs
were counted with a hemocytometer, and 500,000 cells
were aliquoted for transfection with 10 μg linearized plas-
mid DNA as described in the previous section. After trans-
fection, cells were plated in a T-25 flask for culture in
expansion medium. At 48 h post-transfection, expansion
medium was aspirated and replaced with selective medium:
DMEM, 10% FBS and 800 μg/mL G418 (Gibco Life
Technologies). Bone marrow-derived MSCs (9004 BM-
MSC and 9003 BM-MSC) were maintained in selection for
12 d, whereas adipose-derived MSCs (9003 ASC) required
a longer selection window of 16 d. At the end of selection,
cells were rinsed with PBS and fixed with 4% paraformal-
dehyde for 30 min. Then, cells were stained with 0.5%
crystal violet solution for 10 min to visualize neomycin-
resistant colonies. Only discrete colonies that mea-
sured ≥ 2 mm in diameter were counted. Integration of lin-
ear pEGFP-N1 was measured by taking the number of
integrant colonies per total cells transfected. This assay
was performed for each cell line in 4 replicates and the ex-
periment repeated once more. Data from all 8 replicates
were combined to get the average number of integrant col-
onies for each cell line.
Statistical analysis
Using the software SAS 9.3 (SAS Institute), data was an-
alyzed using one-way ANOVA and statistically grouped
using Tukey’s multiple means comparison test. Data was
blocked by experiment, or the blocks removed when the
block effect was not significant. P values are reported for
the ANOVA, while statistical differences with a P value
of less than 0.05 was considered as significant for the
Tukey analysis. Data is represented as means ± SEM.
Results
Colony-forming efficiency (CFE)
All three MSC lines were able to form colonies after
low-density plating (150 cells/55 cm2). As MSCs areheterogeneous, colonies formed were a mixture of dark,
dense colonies of smaller, proliferative cells [Additional
file 1: Figure S1A] and colonies of larger, flatter cells that
were lighter in color [Additional file 1: Figure S1B]. At
P5, there were significant differences in CFE between the
cell lines (P = 0.0008). 9004 BM-MSC exhibited a CFE of
61.0% ± 2.2, which was significantly higher (P < 0.05)
than those of 9003 ASC (48.0 ± 4.2) and 9003 BM-MSC
(40.7 ± 1.9) [Figure 1A].
To investigate the effect of passaging on CFE and
other MSC characteristics, 9004 BM-MSC was expanded
to passages 10, 15 and 20. At higher passages, 9004 BM-
MSC retained colony-forming ability with statistical dif-
ferences observed in CFE between passages (P = 0.03).
The highest CFE was observed in P20 MSCs, in which
53.0% ± 2.1 of cells plated formed colonies. P15 MSCs
exhibited a CFE of 47.4% ± 3.4, while P10 MSCs yielded
a CFE of 43.8% ± 2.7, which was significantly lower com-
pared to P20 MSCs (P < 0.05) [Figure 1B].
Karyotype analysis
All three MSC lines demonstrated chromosomal stability
in vitro, at least up to 5 passages in culture. For each
cell line, the majority of chromosome spreads showed a
normal ploidy level of 2N = 60, with no sign of gross
chromosomal abnormalities observed. The incomplete
spreads were usually characterized by the loss of 1 to 3
chromosomes, which is consistent with chromosome loss
caused by the spreading technique. Examination of
complete metaphase spreads isolated from 9004 BM-MSC
at P10, P15 and P20 revealed a complete set of 60 chromo-
somes with no sign of gross chromosomal abnormalities.
Osteogenic differentiation
All three MSC lines showed capacity for undergoing in-
duced osteogenic differentiation [Figure 2]. Mineralized
calcium deposits stained orange-red with Alizarin Red S.
Control MSCs and the fibroblast line did not exhibit cal-
cium deposition, showing inability to undergo induced
osteogenic differentiation. Differences in the extent of
calcium mineralization between the MSC lines can be
observed by visual comparison. The bone-marrow de-
rived MSCs lines appear to have higher capacity for
osteogenic differentiation, as shown by the greater extent
of staining in 9004 BM-MSC [Figure 2A] and 9003 BM-
MSC [Figure 2C], compared to the adipose-derived 9003
ASC [Figure 2E].
Chondrogenic differentiation
MSCs and ear fibroblasts were able to undergo chondro-
genesis. Differentiated cells underwent morphological
changes, migrating to each other to form ridges and
clumps, whereas control cells remained in monolayer
[Figure 3]. These ridges and clumps of cells stained
Figure 1 Colony-forming efficiency of MSCs. Colony-forming
efficiency (CFE) of P5 MSCs from different sources (A) and 9004
BM-MSC cultured to passages 10, 15 and 20 (B). CFE is expressed as
percentage of colonies formed per total cells plated and presented
as means (± SEM). Statistically significant groups by Tukey’s test are
indicated by letters (P < 0.05).
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aminoglycans prevalent in cartilage. Undifferentiated
monolayers showed little to no staining. Fewer but larger
micromasses were observed in the BM-MSCs, whereas
the ASCs yielded numerous but smaller micromasses. In
1014 ear fibroblasts, there were large micromasses as
well as small ones akin to those found in 9003 ASC.Adipogenic differentiation: cytochemical staining
of adipocytes
Both differentiation methods demonstrated the capacity
of MSCs and ear fibroblasts to undergo adipogenic dif-
ferentiation [Figure 4]. Control cells that were cultured
in expansion medium did not undergo adipogenesis and
did not stain positive with Oil Red O [Figure 4I-L].
However, there were visual differences in the morph-
ology of adipocytes obtained from each differentiation
method. Cells that were differentiated with the Adipo I
method accumulated many small lipid droplets in the
cytoplasm [Figure 4A-D], whereas there were visually
fewer but bigger lipid droplets in cells differentiated
using the Adipo II method [Figure 4E-H].
Adipo I yielded greater percentages of lipid-positive
cells, with significant differences between the cell lines
(P < 0.0001) [Figure 5A]. 9003 ASC exhibited the highest
percentage of lipid-positive cells (8.9% ± 1.0), signifi-
cantly higher than the percentage observed in 9004 BM-
MSC (1.1% ± 0.08, P < 0.05). 9003 BM-MSC and 1014 EF
yielded the lowest percentage of lipid-positive cells
(0.038% ± 0.001 and 0.036% ± 0.02, respectively), signifi-
cantly lower than 9004 BM-MSC (P < 0.05). In Adipo II,
the number of lipid-positive cells was much lower, but
statistical differences were still found among the cell
lines (P < 0.0001) [Figure 5C]. 9003 ASC still yielded the
highest percentage of lipid positive cells (0.40% ± 0.08),
significantly higher than 1014 EF (0.092% ± 0.02, P < 0.05).
9004 BM-MSC only produced 0.051% ± 0.005 lipid-filled
cells, while 9003 BM-MSC induced with the Adipo II
method did not yield any lipid-positive cells.
Upon visual observations throughout the 21-d assay
period of Adipo I, it appeared that the numbers of adipo-
cytes in 9004 BM-MSC and 9003 BM-MSC peaked at the
midpoint of the assay, after which lipid-filled cells were
lost. As the experiment was not planned to be a time-
course, samples were not taken at this time point. Never-
theless, the BM-MSCs alone were differentiated with the
Adipo I method for 10 d in a separate experiment and the
results confirmed the earlier observations [Additional
file 1: Figures S2 and S3]. As for 9003 ASC and 1014 EF,
the number of adipocytes steadily increased throughout
the 21-d period. This phenomenon was not observed in
BM-MSCs differentiated in the Adipo II method, in which
adipocyte numbers steadily increased without loss.
Adipogenic differentiation: expression of adipogenesis
marker genes
The differences in percentage of lipid-positive cells cor-
related with the differences seen in the mRNA expres-
sion of PPARG and FABP4. In Adipo I, there were
significant differences in PPARG and FABP4 expression
among the cell lines (P < 0.0001 for both) [Figure 5B].
9003 ASC showed the highest expression of PPARG at
Figure 2 Osteogenic differentiation of MSCs and fibroblasts. P5 MSCs from 9004 BM-MSC (A, B), 9003 BM-MSC (C, D), 9003 ASC (E, F) and
1014 EF (G, H) were cultured in osteogenic differentiation or control medium, respectively and stained with Alizarin Red S, which stains calcium
deposits red. Calcium mineralization in 9003 ASC (E) appeared less extensive than that of the BM-MSCs (A and C). 1014 EF failed to undergo
osteogenesis, as evident from the absence of staining. (G, H). Representative images are shown at 200X magnification. Scale bars represent 100 μm.
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1014 EF, significantly higher than the other cell lines
(P < 0.05). Expression of PPARG in 9004 BM-MSC
and 9003 BM-MSC was higher than 1014 EF as well,
but the difference was not significant. The expression of
FABP4 in 9003 ASC was also significantly higher than
the other cell lines, at 120.7 ± 38.9-fold higher than the
control (P < 0.05). The expression in 9004 BM-MSC
was only 1.6 ± 0.6-fold higher than the control, whereas
9003 BM-MSC expressed fewer FABP4 transcripts at
0.08 ± 0.01-fold of the control.
MSCs differentiated with the Adipo II method showed
lower differential expression of these genes relative to
the fibroblasts. Significant differences between the celllines were observed for PPARG and FABP4 (P < 0.0001
for both), and the highest expression of both genes was
again seen in 9003 ASC [Figure 5D]. PPARG expression
was significantly higher in 9003 ASC (28.2 ± 5.8-fold,
P < 0.05) compared to the other cell lines, and consist-
ently higher but not significantly so in the BM-MSCs
relative to the fibroblasts, with 9004 BM-MSC showing
4.6 ± 1.2-fold and 9003 BM-MSC showing 2.4 ± 0.3-fold
higher expression relative to 1014 EF. FABP4 expres-
sion again was concordant with observations in adipocyte
counts: 9003 ASC had significantly higher expression at
4.1 ± 0.4-fold above the control cell line 1014 EF (P < 0.05),
while FABP4 expression was lower in 9004 BM-MSC, at
0.42 ± 0.07-fold of the control. 9003 BM-MSC exhibited
Figure 3 Chondrogenic differentiation of MSCs and fibroblasts. P5 MSCs from 9004 BM-MSC (A, B), 9003 BM-MSC (C, D), 9003 ASC (E, F)
and 1014 EF (G, H) were cultured in chondrogenic differentiation or control medium, respectively and stained with Alcian Blue, which
stains cartilage blue. Cellular condensation, as well as ridge and micromass formations that stain positive were observed in 9004 BM-MSC,
9003 BM-MSC, 9003 ASC and 1014 EF cultured in chondrogenic medium (A, C, E, G respectively). Some staining was observed in cells
cultured in control medium, but cells generally remained in monolayer (B, D, F, H respectively). Representative images are shown in phase
contrast at 40X magnification. Scale bars represent 500 μm.
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cantly lower relative expression of FABP4 than that of the
fibroblasts (P < 0.05).
Adipogenic differentiation during long-term culture
The number of lipid-positive cells increased with increas-
ing passages, and was significantly different between pas-
sages (P < 0.0001) [Figure 6A]. After 10 d of differentiation,
56.9% ± 2.9 of P20 MSCs stained positive for Oil Red O,
which was significantly higher than the 45.9% ± 3.7 that
stained positive in P15 MSCs (P < 0.05). P10 MSCs yielded
13.1% ± 0.7 lipid-positive cells, significantly lower than
P15 and P20 MSCs (P < 0.05). The same trend was alsoobserved in gene expression data, which is represented
as relative to control, non-induced MSC cultures at the
corresponding passage [Figure 6B]. Significant differences
in PPARG and FABP4 expression were observed as pas-
sage increased (P = 0.0006 and P < 0.0001, respectively).
PPARG expression in P20 MSCs was the highest, at
3.4 ± 0.5-fold higher than the level in control non-induced
P20 cells, followed by a 3.0 ± 0.3-fold increase in P15
MSCs. PPARG expression in P10 MSCs was significantly
lower, at 1.4 ± 0.3-fold increase relative to control cultures
(P < 0.05). In the case of FABP4 expression, we observed
the same pattern of significance as compared to the
percentage of adipocytes counted. P20 MSCs expressed
Figure 4 Oil Red O staining of MSCs and fibroblasts differentiated using two methods of adipogenic induction. P5 9004 BM-MSC (A, E, I),
9003 BM-MSC (B, F, J), 9003 ASC (C, G, K) and 1014 EF (D, H, L) were differentiated by the Adipo I method (A-D), Adipo II method (E-H), or cultured
in expansion medium (I-L). Differentiated adipocytes accumulated lipid droplets in the cytoplasm that stain red with Oil Red O. Cells cultured in control
medium (I-L) and 9003 BM-MSC induced by Adipo II (F) did not yield lipid-filled adipocytes. Representative images are shown in phase contrast at
200X magnification. Scale bars represent 100 μm.
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induced cells, significantly higher than expression in P15
cells at 3451.3 ± 320.0-fold (P < 0.05). FABP4 expression
was at 774.9 ± 136.0-fold relative to control cells in P10
cells, which was significantly lower compared to P15 and
P20 cells (P < 0.05).
Upon further examination of the Oil Red O-stained
cells, it was apparent that P15 and P20 MSCs contained
more polygonal cells, compared to the largely spindle-
shaped cells in P10 MSCs (data not shown). Control
cells incubated in expansion medium did not yield lipid-
positive cells (data not shown).
Expression of cell surface marker genes
RT-PCR analysis revealed that all three MSC lines and
1014 EF expressed CD90, CD105 and CD73 [Figure 7],which are markers that have been defined as positive cell
surface markers for human MSCs [5]. Expression of the
hematopoietic marker CD45 was not detected in any of
the cell lines, whereas CD34 was detected only in 9003
ASC [Figure 7].
Quantitative RT-PCR analysis showed significant dif-
ferences in CD90 expression (P = 0.0123), in that it was
lower in MSCs compared to 1014 EF [Figure 8A]. CD90
expression in 9004 BM-MSC was 0.93 ± 0.1-fold of the
expression in 1014 EF, whereas 9003-BM MSC and
9003 ASC showed significantly lower expression, with
0.54 ± 0.06-fold and 0.51 ± 0.02-fold expression compared
to 1014 EF (P < 0.05). On the other hand, CD105 expres-
sion was overall higher in MSCs compared to 1014 EF
(P = 0.0004), with 9003 BM-MSC showing significantly
higher expression at 18.3 ± 3.2-fold compared to 1014
Figure 5 (See legend on next page.)
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Figure 5 Adipogenic differentiation capacity of P5 MSCs and fibroblasts. The percentage of lipid-positive cells over total cells counted (± SEM) is
shown for each cell line differentiated with Adipo I (A) and Adipo II (C). Quantitative RT-PCR analysis of PPARG and FABP4 expression was performed on
each cell line differentiated with Adipo I (B) and Adipo II (D), and data is presented as fold change (± SEM) in expression relative to expression levels in
1014 EF (fold change ~1, indicated by the dotted line). Statistically significant groups by Tukey’s multiple means comparison test are indicated by letters
(P< 0.05 for A-D).
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3.8 ± 0.9-fold higher in 9004 BM-MSC and 9003 ASC,
respectively, but the difference was not significant. CD73
expression was not significantly different in MSCs com-
pared to 1014 EF (P = 0.2645).
To determine whether the expression of cell surface
markers change during ex vivo expansion, quantitative
PCR was performed on RNA isolated from 9004 BM-
MSCs at P10, P15 and P20 to examine the gene expres-
sion of CD90, CD105 and CD73. Relative differences in
mRNA expression were calculated using expression levels
in P5 cells as the baseline. The expression of CD90 and
CD73 were found to not change with passaging (P = 0.15
and P = 0.83 respectively) [Figure 8B]. However, the expres-
sion of CD105 increased significantly between P5 and
P10 cells (P = 0.0084), with expression at 3.6 ± 0.2-fold in
P10 MSCs relative to P5 MSCs (P < 0.05). CD105 expres-
sion appeared to plateau sometime after passage 10, show-
ing no difference between P10, P15 and P20 MSCs.
Expression of pluripotency genes and immunofluorescent
detection of OCT4
RT-PCR showed that low expression of OCT4 was de-
tected in all three MSC lines as well as 1014 EF [Figure 7].
SOX2 was also detected in the MSCs and fibroblasts,Figure 6 Adipogenic differentiation capacity of BM-MSCs at higher pa
(± SEM) for 9004 BM-MSC at passages 10, 15 and 20 (A) and quantitative RT-P
as fold change (± SEM) in expression relative to control cells at corresponding
according to analysis by Tukey’s multiple means comparison (P < 0.05).though expression in 9003 ASC appeared to be much
lower. NANOG was faintly detected only in 9003 ASC and
1014 EF, and was either very lowly expressed or not
expressed at all in 9004 BM-MSC and 9003 BM-MSC.
Immunofluorescent staining showed that all the MSC
lines and the 1014 EF stained positive for OCT4 protein.
Fluorescence was clearly restricted to the cytoplasm,
while the nuclei remained dark and unstained [Figure 9].
Staining was also uneven – some cells fluoresced stron-
ger than others, although it was not clear if this was a
result of uneven OCT4 expression or due to uneven
staining. Considering the faint bands detected from RT-
PCR analysis, it is more likely that OCT4 expression in
the cells was uneven. There seemed to be no difference
in fluorescence intensity among the cell lines. In the bo-
vine blastocysts, fluorescence was restricted to only the
nuclei [Figure 9], consistent with known distribution of
OCT4A protein in blastocysts [42,43] and suggesting
that the antibody used bound to both the OCT4A and
OCT4B isoforms.
Transfection and integration of introduced DNA
No significant difference was found in the percentage of
GFP-positive cells among the MSC lines at P5 (P = 0.6049).
Transfection efficiency was 45.3% ± 5.5 in 9004 BM-MSC,ssages. The percentage of lipid-positive cells over total cells counted
CR analysis of PPARG and FABP4 expression for each passage presented
passages (B). Statistically significant differences are indicated in letters
Figure 7 RT-PCR analysis of gene expression in MSCs and
fibroblasts. RT-PCR was performed using primers that amplify the
cell surface markers CD90, CD105, CD73, CD45 and CD34, and the
pluripotency markers OCT4, SOX2 and NANOG. Primers amplifying
GAPDH were used as a positive control for the cDNA. PCR products
were visualized in 2% agarose.
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ASC. Following transfection of linearized pEGFP-N1 and
G418 selection in MSCs, surviving colonies of G418-
resistant cells were counted. Significant differences in
integration per 500,000 cells transfected were found
(P < 0.0001). The number of integrant colonies was signifi-
cantly different between each MSC line, with 9004 BM-
MSC yielding the highest number of integrants (35.2 ± 3.3),
followed by 9003 ASC (25.5 ± 5.8) and 9003 BM-MSC
(12.8 ± 1.1) (P < 0.05) [Figure 10A].
To investigate whether long-term expansion of MSCs
in vitro affect their potential for genetic modification,
the transfection and integration of 9004 BM-MSCs at
higher passages were examined. No significant difference
was observed in the percentage of GFP-positive cells
among MSCs at different passages (P = 0.62). Transfec-
tion efficiency was 24.4% ± 1.6 in P10 MSCs, 22.4% ± 1.5
in P15 MSCs and 23.4% ± 1.0 in P20 MSCs. Following
transfection of linearized pEGFP-N1 and G418 selection
in MSCs, a decreasing trend in integrant colony number
was observed as passage number increased (P = 0.035).
The number of integrants was the highest in P10 MSCs
(15.6 ± 1.4), and progressively decreased in number in
P15 MSCs (15.3 ± 1.0) and P20 MSCs (11.5 ± 1.0),
with P20 having significantly fewer integrants than P10
(P < 0.05) [Figure 10B].
Discussion
Our results indicate that the 9004 BM-MSC, 9003 BM-
MSC and 9003 ASC are true mesenchymal stem cells, as
evidenced by their ability to undergo trilineage differen-
tiation [5]. 1014 EF was able to undergo adipogenic
and chondrogenic differentiation, but not osteogenesis,
hence distinguishing fibroblasts from MSCs. Fibroblasts
can be isolated from multiple tissues; as a result, differ-
entiation potentials reported for fibroblasts have been
variable, such as being only capable of chondrogenesis
[25,44], exhibiting trilineage differentiation at a lower
capacity [25,45], or not at all [3]. In this study, goat ear
fibroblasts lacked osteogenic capacity. In all cases, fibro-
blasts do not exhibit trilineage differentiation potential
at the same capacity as MSCs, making it a more reliable
method for distinguishing MSCs from fibroblasts, com-
pared to cell surface marker expression.
Based on our results, adipogenic differentiation cap-
acity in MSCs appears to be impacted by source tissue.
Figure 8 (See legend on next page.)
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Figure 8 Cell surface marker expression in MSCs and fibroblasts. Quantitative RT-PCR was used to measure the expression of the cell surface
markers CD90, CD105 and CD73 in P5 MSCs (A) and in 9004 BM-MSCs at passages 10, 15 and 20 (B). Expression levels are presented as fold
change (± SEM) relative to 1014 EF (A) or expression levels in P5 9004 BM-MSC (B) (fold change ~1, indicated by the dotted line). Statistically
significant groups by Tukey’s multiple means comparison test are indicated by letters (P < 0.05). Significant differences between the cell lines were
observed in CD90 and CD105 expression. Significant difference between the different passages was observed in CD105, but not in CD90
and CD73.
Figure 9 Immunofluorescent staining of OCT4 in MSCs and fibroblasts. P5 cells were stained with antibodies against OCT4. OCT4 was
localized in the cytoplasm of MSCs and fibroblasts, whereas staining for OCT4 was specific to the nuclei in the bovine blastocyst. Representative
images are shown at 200X magnification.
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Figure 10 Transfection and integration efficiency in MSCs. P5
MSCs (A) and 9004 BM-MSC at passages 10, 15 and 20 (B) were
transfected with pEGFP-N1. Integrant number were expressed as the
number of discrete colonies that were resistant to G418 selection.
Statistically significant groups by Tukey’s test is indicated by letters
(P < 0.05). 9004 BM-MSC showed the highest number of integrants,
followed by 9003 ASC and 9003 BM-MSC. 9004 BM-MSC showed a
decreasing trend in number of integrants with increasing passages.
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BM-MSCs, as reported for other species [8,9]. This could
be explained by intrinsic epigenetic differences that primes
resident MSCs in different source tissues to differentiate
into the surrounding tissue. This is consistent with the
finding that MSCs derived from adipose, bone marrow and
muscle have similar but not identical promoter methyla-
tion profiles [46]. According to a review by Boquest et al.
[47], studies showed that undifferentiated ASCs are epige-
netically primed for adipogenesis. We also saw significant
differences between two lines of BM-MSCs isolated from
two donor goats. Large donor-to-donor variability in adi-
pogenic differentiation of BM-MSCs also was seen in a
study by Aldridge et al. [48]. Even though observations on
our goat MSCs are consistent with what has been seen in
MSCs of other species, it is difficult to draw the same con-
clusions based on only one ASC line and two BM-MSC
lines. Future studies should aim to solidify these findings
with more MSC isolates.
In this study, fibroblasts derived from ear cartilage
were observed to be capable of adipogenic differentiation
at a low capacity, as seen with other isolated fibroblast
lines [25,48] and suggesting a rare subpopulation of
mesenchymal progenitors reside in fibroblast prepara-
tions [49]. Consistent with our results, Alt et al. [25] also
observed significantly more Oil Red O-staining adipo-
cytes in human ASCs compared to skin fibroblasts.
Stress-induced lipid accumulation in the fibroblasts is
also a possibility, such as lipid formation due to over-
confluence [50] and not adipogenesis.
After 21 d of adipogenic differentiation, the BM-MSCs
appeared to exhibit a low adipogenic potential, and in
some cases, even lower than the fibroblast cell line.
However, from visual observations throughout the 21-d
period of adipogenic differentiation via the continuous
induction method (Adipo I), lipid-positive cells in BM-
MSCs were seen to increase until approximately 10 d
and appear to subsequently decrease in number. Adipo-
genic cell counts in both BM-MSC lines at Day 10 were
found to be higher than the numbers acquired at Day 21
[Additional file 1: Figure S3]. Thus, the adipocyte count
in BM-MSCs after 21 d of differentiation do not repre-
sent the maximal number that could be achieved in
these cell lines, and although Adipo I did indeed yield
greater numbers, this differentiation method was not
able to sustain adipocyte numbers past two weeks of cul-
ture. The loss of adipocytes in BM-MSCs could either be
explained by external aspects, such as composition of
culture media, or intrinsic factors, such as the nature of
the cells themselves. Bosch et al. [51] showed a plateau
in number of lipid-positive cells after 10 d in porcine
BM-MSCs. It is possible that the media compositions
used are not sufficient to maintain BM MSCs differ-
entiating down the adipogenic lineage, and needs to
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and pigs.
In our study, we observed an increase in adipogenic
differentiation capacity as passage number increased in
9004 BM-MSCs, as shown by adipocyte counts and
mRNA expression of PPARG and FABP4. This is con-
cordant with the observed increased adipogenesis in
late-passage porcine BM-MSCs [52]. On the other hand,
studies in rhesus macaque and human BM-MSCs show
a decrease in adipogenic potential at higher passages
[29,30,53]. These opposing results could be due to
species-specific differences in the biology of MSCs. Also,
an increase in CFE with passaging was observed, sug-
gesting that the passage-related increase in adipogenic
potential could also be attributed to the increased pro-
portion of progenitor cells within the MSC culture. If
this were the case, overall enhanced trilineage differenti-
ation should be observed. Alternatively, should the increase
in adipogenicity be due to shifts in the multipotentiality of
the progenitor cells and not their numbers, an inverse
effect between adipogenesis and osteogenesis is possible
[54-57]. A concomitant increase in osteogenic potential
has been demonstrated with the decrease in adipogenic po-
tential [30,53], or vice versa [52]. Further research should
investigate the effects of passaging on the osteochondro-
genic potential of goat BM-MSCs, and whether the same
trend occurs in goat ASCs. This is especially relevant as
goat MSCs are often utilized in bone and cartilage tissue
engineering applications.
MSC cultures are known to be heterogeneous [58].
Therefore, each MSC isolation will have a heterogeneous
mixture of cells – each may have a different proportion
of mesenchymal progenitor cells, which is demonstrated
by the difference in differentiation capacity and low
density CFE shown in this work. The colony-forming
unit (CFU) assay, or colony-forming efficiency assay, is
an assay that measures the ability of a cell line or isolate
to propagate and form colonies originating from single
cells after plating at a very low density. CFU assays are
useful in estimating the proportion of early progenitors
in different preparations of MSCs [59]. A positive correl-
ation between CFE and differentiation capacity have
been demonstrated in other studies [29,60,61]. In this
study, between the BM-MSC lines, the cell line with the
higher CFE (9004 BM-MSC) was also observed to have
higher differentiation capacity. When cultured through
higher passages, 9004 BM-MSC exhibited an increase in
CFE, suggesting that long-term in vitro culture, at least
up to 20 passages, selects for progenitor cells as they can
self-renew.
Goat MSC lines express CD90, CD105 and CD73, but
do not express CD45, concordant with the minimal cri-
teria set for defining human MSCs [5]. However, thus
far, trilineage differentiation appears to be a more reliablemethod for identifying MSCs as it is consistent across spe-
cies, whereas the expression of cell surface markers is
more variable. For example, CD90 expression is variable
in the mouse [62,63] and is not expressed in rabbit MSCs
[64]. Furthermore, the positive cell surface markers de-
fined for MSCs are also expressed in fibroblasts [25,31,65],
as shown in our study as well. Thus, these positive cell
surface markers are not ideal for characterizing MSCs,
given that MSCs share morphological and other character-
istics with fibroblasts. Finding markers that distinguish
MSCs from fibroblasts is important, as like MSCs [1],
fibroblasts can also be found in virtually all tissues of
the body and are morphologically similar to MSCs. As
such, other research groups have endeavored to identify
markers that distinguish MSCs from fibroblasts [31,66],
and also use fibroblasts as a control cell line in MSC
characterization experiments [44,67].
Data from qRT-PCR of cell surface markers showed
that CD90 and CD73 mRNA levels did not change be-
tween passages 5 and 20. CD105 appeared to increase
between passages 5 and 10, but did not change in fur-
ther passages. CD105 was defined as a positive marker
for its prevalence in MSCs at isolation [5], and was used
to select for a more ‘pure’ MSC population [68]. Since
no difference in CD105 expression was detected in 9004
BM-MSC between passages 10 and 20, while significant
difference in adipogenesis was observed, it is unlikely
that CD105 expression is related to adipogenic potential
in MSCs. A study by Lysy et al. [69] also showed no link
between CD105 expression and adipogenic capacity in
MSCs and fibroblasts, whereas lung fibroblasts that also
express CD105 were not able to undergo adipogenesis
[25]. The fact that CFE in 9004 BM-MSC at passage 5
and 10 were comparable indicates that the increase in
CD105 expression cannot be attributed to a growing
number of progenitor cells. CD105, or endoglin, is a
transmembrane protein involved in TGF-β signaling
[70]. CD105 is required for angiogenesis [71] and is reg-
ulated during heart development [72]. Since MSCs are
known to promote angiogenesis [73,74], perhaps the in-
crease in CD105 expression is indicative of an increase in
angiogenic potential. It has been shown that gene expres-
sion data of cell surface markers is representative of protein
expression measured in flow cytometry [31]; thus, quanti-
tating gene expression could be useful to estimate the per-
centage of cells expressing certain markers, when the use
of antibodies prove to be difficult due to lack of availability
and cross-reactivity in certain species, such as the goat.
Nevertheless, there is still a need for antibodies with speci-
ficity to goats, as flow cytometry can provide information
on marker expression on a per cell basis and has the po-
tential to reflect heterogeneity in the MSC population.
Expression of CD34, a negative cell surface marker for
MSCs defined by Dominici et al. [5] was detected in
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statement of the International Federation for Adipose
Therapeutics and Science (IFATS) and the International
Society for Cellular Therapy (ISCT) that CD34 expres-
sion in adipose-derived MSCs is variable and generally
detected at early passages [10]. This could be due to het-
erogeneity in the early phase of ASC culture, as ASCs
have been found to be more homogeneous in later pas-
sages [75]. This is consistent with the high standard de-
viation seen in the CFE of 9003 ASCs (which was due to
differences between biological replicates, not technical
replicates), suggesting a greater heterogeneity in the
cell line. Detection of CD34 expression in early passage
ASCs due to contamination of hematopoietic cells is also
possible, and more population doublings in culture may
be needed to attain homogeneity [63]. Another possible
explanation is that CD34 is gradually lost in ASCs in
ex vivo culture [75,76].
In this study, the expression of the pluripotency-
associated transcription factor genes OCT4, SOX2 and
NANOG were detected in our goat MSCs by RT-PCR,
and OCT4 protein was detected by immunofluores-
cence. In the immunofluorescence experiment, OCT4
was shown to be localized exclusively in the cytoplasm
of MSCs. This is consistent with the OCT4B isoform,
which is the isoform associated with cell stress response
[77,78] and has been shown to be cytoplasmic [43,79].
Localization of OCT4A, the isoform that is associated
with pluripotency, is restricted to the nuclei of pluripo-
tent cells [43,79]. Cytoplasmic localization has been
demonstrated in other reports of OCT4 detection in
MSCs [29,80,81], confirming that the OCT4 isoform de-
tected in MSCs is most likely OCT4B. A study on goat
umbilical cord MSCs, which were reported to be more
primitive, showed that OCT4 and SOX2 expression was
more restricted to the nucleus with some expression in
the cytoplasm, but with NANOG expression completely
restricted to the cytoplasm [22]. When working with
antibodies, one has to consider the possibility of non-
specific staining, especially when using antibodies spe-
cific to other species and when no positive or negative
control was used. One study reported that the detection
of OCT4 and SOX2 expression in the nucleus and the
cytoplasm varied with the different commercial anti-
bodies used [82], demonstrating the questionable nature
of the detection of these proteins in adult stem cells and
the importance of using controls. In our study, we
showed that the antibody used against OCT4 is specific
to the nucleus in a bovine blastocyst, suggesting that the
antibody was not isoform specific, and thus could be
used to show differing localization that correlates with
different isoforms. We also tried an antibody against
NANOG in our study, which cross-reacted in our MSCs,
but showed non-specific reactivity in bovine blastocysts(data not shown). OCT4, NANOG and SOX2 were also
expressed in the fibroblast line 1014 EF; it is then likely
that these genes perform a different function in adult
cells that is unrelated to pluripotency, or no function at
all. This is supported by the observation that knocking out
OCT4 in MSCs as well as other somatic stem cells did not
affect their self-renewal and multipotential abilities [83].
Investigating transfection and integration of introduced
DNA constructs in MSCs is interesting for assessing their
potential use in genetic engineering. The integration effi-
ciencies observed in our goat MSCs are similar to the low
efficiencies of random integration seen in other mamma-
lian cells [84]. Haleem-Smith et al. saw no significant differ-
ences in transfection efficiency of human BM-MSCs from
different donors [85], consistent with our findings. Never-
theless, they demonstrated higher Nucleofection efficien-
cies compared to ours, which could be explained by our
use of a different plasmid [85], as well as the fact that the
kits and protocols available were optimized for human
MSCs and not goat MSCs. We also observed that, com-
pared to 9004 BM-MSC, 9003 BM-MSC yielded signifi-
cantly fewer integrant colonies and also lower CFE. This is
unsurprising, as the subpopulation of cells that can attach
and proliferate from low-density plating should represent
the cells that are robust enough to stably integrate intro-
duced DNA constructs, survive selection and proliferate
into colonies of integrants.
Long-term ex vivo expansion of goat BM-MSCs may
also have altered the proportion of MSC subpopulations.
Higher passage BM-MSCs contained more enlarged, flat-
tened and polygonal cells, which could be indicative of
an increase in the large, flat and polygonal Type II sub-
population of MSCs [86,87], which proliferate slower
and tend to increase in proportion in higher passage
MSCs [86,88]. A large number of the lipid-filled adipo-
cytes in P15 and P20 MSCs are rounded and appear less
attached to the substrate, suggesting that the flatter cells
may be less structurally supportive to adjacent cells.
Additionally, a progressive decrease in G418-resistant in-
tegrant colonies from transfections was observed, even
though DNA uptake ability of MSCs did not change
with passaging. This suggests that genetic modification
of higher passage MSCs may be less efficient due the in-
crease of in the slow-growing Type II subpopulation that
may be less robust against selection procedures. MSCs
have been genetically modified in vitro for various appli-
cations, such as enhancing tissue regeneration [89,90] or
utilizing MSCs as delivery vehicles for transgene prod-
ucts [91-93]. In exploring the application of in cell-based
therapy and tissue engineering, it is useful to investigate
whether ex vivo expansion alters their amenability to
genetic modification.
Our results show that two different adipogenic dif-
ferentiation protocols resulted in significantly different
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percentage of Oil Red O-positive cells. MSCs that were ex-
posed to alternating induction and maintenance media
produced larger fat droplets than those produced by MSCs
that were exposed to the same adipogenic medium consist-
ently. The different patterns of adipogenesis due to differ-
ent induction method show that MSCs could potentially
be used as an in vitro model for illustrating adipogenesis
[94]. There have been studies conducted on more differen-
tiated cell types, such as immortalized pre-adipocytic cell
lines or mature adipocytes from the stromal-vascular frac-
tion in digested adipose tissue, as in vitro models to eluci-
date mechanisms involved in adipogenesis [95,96]. Using
adult stem cells like MSCs could bring another dimension
to these studies; for instance, the mechanisms of differenti-
ation and adipogenic lineage commitment could be exam-
ined as well.
Measuring adipogenic capacity by counting adipocytes
is laborious, but is more informative as it takes into ac-
count the number of cells that actually differentiated.
Methods that measure adipogenesis by solubilizing dyes
and measuring absorbance do not provide information
on the number of adipocytes or the average levels of
lipids per cell. On the other hand, counting cells pro-
vides information on the number of cells that actually
differentiated, and may be a better representation of adi-
pogenic capacity and has been employed in other studies
as well [25]. As demonstrated by our results, different
methods of differentiation may yield more Oil Red O
staining that do not necessarily equal to more adipo-
cytes. It has been established that FABP4 is one of the
best markers of adipogenesis due to its significant upreg-
ulation after adipogenic induction [97]. Moreover, our
results showed that FABP4 expression is highly correla-
tive to the number of lipid-positive cells in a given treat-
ment. The large standard deviation seen in 9003 ASC’s
FABP4 expression (but not in PPARG), which was due
to a large difference between the two biological repli-
cates, mirrors the large standard deviation seen in the
adipocyte count as well. The expression of FABP4 (but
not PPARG) in 9003 BM-MSC was also concordant with
the adipocyte count, demonstrating that FABP4 expres-
sion could be a reliable representation of adipocyte count.
Hence, measuring FABP4 mRNA could be used as quick
measurement of the extent of adipogenesis within a given
cell line. It was also shown in another study that semi-
quantitative scoring of lipid staining was highly correlative
to FABP4 protein quantification via flow cytometry, which
also provides information on a per cell basis [48]. Results
from our study and others [48] showed that PPARG ex-
pression was not representative of the extent of adipogenic
differentiation, suggesting that expression of the early
marker PPARG is not indicative of the progression of adi-
pogenic differentiation.Conclusions
Our experiments demonstrate that 9004 BM-MSC, 9003
BM-MSC and 9003 ASC are indeed goat MSCs, as evi-
denced by their ability to undergo osteogenic, chondro-
genic and adipogenic differentiation. Like human MSCs,
goat MSCs also express CD90, CD105 and CD73, and
do not express the hematopoietic marker CD45. As evi-
denced by CFE, different MSC isolations from the same
tissue type can result in significantly different quantities
of progenitor cells. Thus, performing a colony-forming
assay early in a MSC culture may be useful to assess the
purity of a MSC isolate and influence choice of cell lines
for future experiments.
This study also sheds light on how the donor, source
tissue and passage number of goat MSCs could lead to
differences in adipogenic differentiation. Cytochemical
staining and gene expression analysis showed that the
goat ASC line had a greater capacity for adipogenic dif-
ferentiation compared to the two BM-MSC lines. Goat
fibroblasts were also able to undergo adipogenic differ-
entiation, but at a low capacity. The differences in adipo-
genic potential between two BM-MSC lines demonstrate
donor-to-donor variability between MSCs isolated from
the same tissue, even when the donors were siblings
from the same litter. Last but not least, passaging and
prolonged ex vivo culture of BM-MSCs had an impact
on adipogenicity as well.
In conclusion, this study provides further characterization
information on goat MSCs, as well as an insight to how
MSC characteristics change during ex vivo expansion. BM-
MSCs expanded over increasing passages in vitro main-
tained karyotypic stability up to 20 passages in culture,
exhibited an increase in adipogenic differentiation and CFE,
but showed altered morphology and amenability to genetic
modification by selection. Different methods of inducing
adipogenesis also affect the extent and profile of adipogenic
differentiation in MSCs, indicating the potential of goat
MSCs as an in vitro model for adipogenesis for ruminant
species.
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